Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Xcytrin enters pivotal trial for treatment of brain metastases in NSCLC patients

Dec. 30, 2002

Epothilone B effective and well tolerated in advanced breast cancer

Dec. 30, 2002

Clinical results reported for lonafarnib in hematological malignancies

Dec. 30, 2002

Efficacy and safety of tipifarnib in leukemia and other hematological disorders

Dec. 30, 2002

Prinomastat monotherapy in low-risk myelodysplastic syndrome

Dec. 30, 2002

New data on the HDAC inhibitor MS-275 in leukemia

Dec. 30, 2002

Decalactones of fungal origin reported to exhibit antitumor and antiinfective activity

Dec. 27, 2002

CP-461 well tolerated in a phase I trial in patients with advanced cancer

Dec. 27, 2002

Arzoxifene and LG-100268 effective alone and in combination in a rat breast cancer model

Dec. 27, 2002

SN-38 induces cell cycle arrest and apoptosis in human testicular cancer cells

Dec. 27, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 5, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.